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A B S T R A C T
Methylsulfonylmethane (MSM) is a natural organosulfur compound has been widely used as a dietary
supplement. MSM has protective eﬀects against various disorders through its anti-inﬂammatory and
antioxidant properties however the eﬀect of MSM on gastric mucosal injury remains unclear. The aim of the
present study is to determine whether MSM has beneﬁcial eﬀects on ethanol/HCl-induced gastric ulcer in mice.
Macroscopic and histopathological evaluation of gastric mucosa revealed that ethanol/HCl administration
produced apparent mucosal injuries, while pretreatment with MSM (200 and 400 mg/kg, orally) could
eﬀectively protect gastric mucosa against the injuries caused by acidiﬁed ethanol. MSM signiﬁcantly increased
the levels of glutathione (GSH), catalase (CAT) and prostaglandin E2 (PGE2), and decreased the levels of
malondialdehyde (MDA), myeloperoxidase (MPO), carbonyl protein, and nitric oxide (NO) in gastric tissues
compared with those in the ethanol group. MSM suppressed gastric inﬂammation by reducing the levels of
proinﬂammatory cytokines tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, monocyte chemoattractant
protein (MCP)-1 and matrix metalloproteinase (MMP)-9. Moreover, pretreatment of mice with MSM decreased
the expression of nuclear factor kappa B (NF-κB) as a key regulator of inﬂammation in gastric mucosa. Taken
together, these data suggest that MSM is able to decrease the severity of ethanol/HCl-induced gastric mucosal
injury through inhibition of oxidative stress and inﬂammation.
1. Introduction
Peptic ulcer is a chronic multifactorial disease of the gastrointest-
inal tract that aﬀects the mucosal lining of the stomach. The patho-
physiology of gastric mucosal injury results from an imbalance between
defensive factors, such as gastric mucus, bicarbonate and prostaglandin
E, and aggressive factors such as gastric acid, pepsin, non-steroidal
anti-inﬂammatory drugs (NSAIDs), alcohol and Helicobacter pylori
infection (Pérez et al., 2017). It has been demonstrated that alcohol
consumption causes gastric mucosal injury through direct eﬀects such
as gastric epithelial cell damage and indirect eﬀects such as the
recruitment of leukocytes and induction of inﬂammation and oxidative
stress (Kang et al., 2017). Ethanol metabolism results in the production
of large amounts of reactive oxygen species (ROS) including the
superoxide radicals, hydrogen peroxide and peroxynitrite. Ethanol also
signiﬁcantly diminishes the levels of antioxidant agents that can
remove ROS. The imbalance between the formation and removal of
free radicals plays an important role in the pathogenesis of gastric
mucosal damage (Yu et al., 2014; Amirshahrokhi and Khalili, 2016a). It
has also been shown that inﬁltration of neutrophils into the gastric
mucosa and release of proinﬂammatory cytokines such as TNF-α, IL-
1β, IL-6 and chemokine MCP-1 have a critical role in the development
of gastric mucosal inﬂammation and injury (Amirshahrokhi and
Khalili, 2015a; Watanabe et al., 2004). Nuclear factor-kappa B (NF-
κB) is an important transcription factor that regulates inﬂammatory
processes in gastric mucosal damage (Arab et al., 2015). Prostaglandin
E (PGE) has been shown to protect gastric mucosa from gastric
irritants and the decreased formation of PGE aggravates peptic ulcer
disease (Hoshino et al., 2003). In the recent few years, many alternative
medicines from natural resources are considered for treatment of
gastric ulcer disease (Boeing et al., 2016; Sidahmed et al., 2013).
Methylsulfonylmethane (MSM) or dimethyl sulfone is a natural
organosulfur compound (Fig. 1A) found in many green plants, fruits,
vegetables and grains. MSM is widely used as a dietary supplement in
worldwide and is believed to be nontoxic to humans. MSM is
considered as an important source of sulfur for the production of the
sulfur-containing amino acids methionine and cysteine. Clinical and
experimental studies have shown potential preventive and therapeutic
eﬀects of this compound. MSM has not been approved by FDA however
it has no toxicity in human studies and is generally recognized as safe
by the FDA. MSM has been shown to possess strong antioxidant and
anti-inﬂammatory activities in many studies (Amirshahrokhi and
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Bohlooli, 2013). It has been reported that MSM improves symptoms of
pain and physical function in patients with knee osteoarthritis (Kim
et al., 2006). MSM has been shown to protect against obesity-induced
metabolic disorders, constipation, hyperacidity, mucous-membrane
inﬂammation, intestinal cystitis, colitis and liver damages through its
anti-inﬂammatory and antioxidant properties (Sousa-Lima et al., 2016;
Parcell, 2002; Amirshahrokhi et al., 2011).
We hypothesized that, because of its antioxidant and anti-inﬂam-
matory eﬀects, MSM may prevent gastric mucosal injury. In this study,
we investigated the possible eﬀectiveness and the mechanisms of action
of MSM on ethanol/HCl-induced gastric ulcer in mice.
2. Material and methods
2.1. Animals
Experiments were performed on Swiss albino mice weighing 25–
30 g. Animals were kept in our animal house under controlled
conditions and allowed free access to water and a standard diet. Mice
were fasted overnight with free access to water before the induction of
gastric ulcers. Animal experiments were conducted in accordance with
the National Institute of Health's Guide for the Care and Use of
Laboratory Animals (NIH publication 85-23, revised 1996). Study
protocol (1395.129) was approved by the animal ethics committee.
2.2. Materials
2,4-dinitrophenylhydrazine, guanidine hydrochloride, trichloroace-
tic acid, potassium phosphate and Tris–HCl, 5,5′-Dithiobis-2-nitro-
benzoic acid, tetramethylbenzidine, thiobarbituric acid, glutathione
reduced, 1,1,3,3-tetraethoxypropane, hydrochloric acid, hydrogen per-
oxide and methylsulfonylmethane were purchased from Sigma-Aldrich.
Protease inhibitors (Complete Mini tablets) were purchased from
Roche (Germany).
2.3. Experimental design
Administration of ethanol/HCl has long been used as an experi-
mental model to induce gastric mucosal lesions in mice. This model has
many clinical and pathophysiologic similarities to human peptic ulcer
disease (Lu et al., 2014; Oliveira et al., 2012). The animals were
randomly divided into ﬁve groups (8 mice per group). The ﬁrst group
served as normal control group and received vehicle only (0.9% saline,
orally). The second group of mice was given MSM (400 mg/kg, orally)
alone. The third group of mice was given a single dose of acidiﬁed
ethanol orally. The fourth group was given MSM (200 mg/kg, orally)
and acidiﬁed ethanol. The ﬁfth group was given MSM (400 mg/kg,
orally) and acidiﬁed ethanol. MSM was dissolved in saline and
administered by gavage 1 h before ulcer induction. After pretreatment
with MSM the animals received acidiﬁed ethanol (60% ethanol/0.15 M
HCl, 0.1 ml/10 g body weight, orally) to induce gastric mucosal
damage. The dose of MSM used in this study was selected based on
our preliminary experiments.
2.4. Sample collection
One hour after administration of ethanol/HCl all animals were
anesthetized with ketamine and xylazine and their stomachs were
immediately removed. The stomachs were opened along the greater
curvature and rinsed with cold saline solution to remove the gastric
Fig. 1. (A) Chemical structure of MSM (B) Eﬀect of MSM on the macroscopic appearance of the gastric mucosa in ethanol/HCl-induced gastric mucosal lesions in mice. (a) Normal, (b)
MSM (400 mg/kg) only, (c) ethanol/HCl, (d) MSM (200 mg/kg) + ethanol/HCl and (e) MSM (400 mg/kg) + ethanol/HCl. (C) gastric ulcer index in each experimental group. The results
are the mean ulcer score ± S.E.M. (n = 8). #P < 0.001 compared with normal group; *P < 0.05, **P < 0.01 compared with ethanol/HCl control group.
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contents and blood clots. Each gastric tissue sample was cut into two
parts; one part was ﬁxed in formalin for the histological analysis and
another part was frozen in liquid nitrogen and kept at − 80 °C for
biochemical analysis.
2.5. Determination of gastric ulcer index
The degree of ethanol/HCl induced gastric mucosal injury was
expressed as ulcer index (UI) (Oliveira et al., 2012) Ulcer index was
measured based on the number and length of the lesions by using
following formula: UI = Σ (A) + (2B) + (3C) (A is the number of small
lesions up to 1 mm; B is the number of lesions up to 3 mm; C is the
number of linear lesions greater than 3 mm). The mean UI was
calculated for each group and statistically analyzed.
2.6. Histopathological analysis
Gastric biopsies were ﬁxed in 10% formalin solution and embedded
in paraﬃn. The paraﬃn blocks were cut into sections of 4 µm thickness
and were stained with hematoxylin and eosin (H& E). The histological
evaluation was performed under light microscopy by an expert
pathologist. Gastric microscopic damage was scored according to the
criteria as described previously (Laine et al., 1988): (1) mucosal edema
(score 0–4), (2) Hemorrhage (score 0–4), (3) inﬂammatory cell
inﬁltration (score 0–3) and (4) epithelial cell loss (score 0–3).
2.7. Preparation of gastric tissue homogenate
The gastric tissue samples were homogenized in ice-cold Tris–HCl
buﬀer (pH 7.4, containing protease inhibitor cocktail) using a homo-
genizer (Heidolph, Germany). The homogenized samples were centri-
fuged at 20,000 g for 20 min in a refrigerated centrifuge at 4 °C. The
supernatants were collected and stored at − 80 °C for biochemical
examination.
2.8. Measurement of reduced glutathione (GSH)
Gastric GSH levels were determined by a modiﬁed Ellman's
method. Brieﬂy, 50 μl of 10% trichloroacetic acid (TCA) was added to
50 μl of the supernatant to precipitate the proteins. After shaking, the
mixtures were centrifuged at 10,000 g at 4 °C for 5 min and the
supernatants were separated from the pellets. 50 μl of the resulting
supernatants were added to 150 μl of phosphate buﬀer (0.2 M, pH 7.6,
1 mM EDTA) and 1 mM DTNB (5,5′-Dithiobis-2-nitrobenzoic acid).
Absorbance was measured at 412 nm using a microplate reader and
results were expressed as μmol/mg protein.
2.9. Measurement of catalase (CAT)
Catalase activity of each sample was measured according to the
modiﬁed method of Aebi (1984). Brieﬂy, a 10 μl of each supernatant
was added to a cuvette containing 0.5 ml of phosphate buﬀer (50 mM,
pH 7). The reaction was initiated by the addition of 0.5 ml hydrogen
peroxide (30 mM) to the reaction mixture and the change in absor-
bance was measured at 240 nm against a blank containing phosphate
buﬀer by using a spectrophotometer (Shimadzu UV-1800, Japan). One
unit of enzyme activity was deﬁned as the amount of enzyme that
catalyzes the decomposition of 1 mM hydrogen peroxide per minute.
2.10. Measurement of malondialdehyde (MDA) levels
Malondialdehyde is one of the end-products of lipid peroxidation
and commonly used as a reliable biomarker of lipid peroxidation
process in tissues. The levels of MDA in the gastric tissues were
determined using the thiobarbituric acid (TBA) method. Brieﬂy, 100 μl
of the supernatant was added to a reaction mixture containing 100 μl of
20% (w/v) TCA and 200 μl of TBA (0.1 M). The reaction mixture was
incubated for 1 h at 90 °C. After cooling, the samples were centrifuged
at 10,000 g for 5 min and the supernatants were collected. The
absorbance value of the supernatants was measured at 532 nm on a
96-well microplate reader (BioTek, USA). The results were expressed as
μmol/mg protein.
2.11. Measurement of carbonyl proteins
Protein carbonylation is widely used as a biomarker of oxidative
damage to proteins, and reﬂects cellular damage induced by ROS. The
content of carbonyl proteins in the gastric tissue was measured by
reaction with 2,4-dinitrophenylhydrazine (DNPH) (Amirshahrokhi and
Khalili, 2016b). Brieﬂy, 50 μl of the sample was added to 100 μl of
10 mM DNPH in 2 M HCl and incubated at room temperature for 1 h.
Then, 100 μl of 20% TCA was added to the mixture and centrifuged at
15,000 g for 5 min. The supernatants were discarded, and the pellets
were washed with 1 ml ethanol-ethyl acetate (1:1 v/v) to remove excess
DNPH. The ﬁnal pellets were resuspended in 150 μl of 3 M guanidine
hydrochloride in 10 mM potassium phosphate (pH 2.3). The absor-
bance of the solutions was measured at 370 nm and the level of
carbonyl proteins was calculated using the molar extinction coeﬃcient
of 22 mM−1 cm−1. The results were expressed as nmol carbonyl per mg
protein.
2.12. Measurement of prostaglandin E2 (PGE2)
The levels of PGE2 in the gastric tissues were measured using a
PGE2 assay kit (Enzo Life Sciences) according to the manufacturer's
protocol. The results were expressed as pg/mg protein.
2.13. Measurement of nitric oxide (NO)
The concentrations of nitrite and nitrate as an index of NO
production in the gastric tissue were assessed. The levels of NO were
measured using a Nitric Oxide Assay Kit (Enzo Life Sciences) and the
results were expressed as μmol/mg protein.
2.14. Measurement of myeloperoxidase (MPO)
The activity of MPO in the gastric tissues was determined by
measuring the oxidation of tetramethylbenzidine (TMB). Brieﬂy, 50 μl
of the specimens was added to 50 μl of TMB solution (15 mM). The
reaction was started by adding 100 μl of H2O2 (25 mM) diluted in
phosphate buﬀer (50 mM, pH 5.4). The rate of change in absorbance
was measured at 370 nm using a microplate reader. One unit of MPO
activity was deﬁned as the quantity of enzyme degrading 1 μmol of
hydrogen peroxide per min at 25 °C. The results were expressed as U
MPO/mg protein.
2.15. Measurement of inﬂammatory cytokines and chemokine
The levels of pro-inﬂammatory cytokines TNF-α, IL-1β, IL-6 and
chemokine MCP-1 in the gastric tissue were determined by using
mouse ELISA kits from eBioscience according to the manufacturer's
instructions. The results were expressed as pg/mg protein.
2.16. Measurement of matrix metalloproteinase-9 (MMP-9)
The plasma levels of MMP-9 were measured by using an ELISA kit
(Mouse Total MMP-9 Quantikine ELISA Kit, R &D Systems) according
to the manufacturer's instructions. The plasma levels of MMP-9 were
presented as ng/ml.
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2.17. Quantitative real-time PCR analysis of NF-κB in lung tissue
Total RNA was extracted from gastric tissue of each group using
TRIzol Reagent (Roche). To avoid DNA contamination, The RNA
samples were treated with DNase I. Synthesis of the cDNA was carried
out using a First Strand cDNA Synthesis Kit (Thermo Scientiﬁc, USA)
according to the manufacturer's instructions. The cDNA samples in
each group were then used as the template for SYBR Green I-based
real-time PCR using the LightCycler (Roche). Thermal cycling condi-
tions were as follows: an initial denaturation at 94 °C for 5 min,
followed by 40 cycles of 10 s of denaturing at 94 °C, 15 s of annealing
at 59 °C, and 15 s of extension at 72 °C. The sequences of primers used
were as follows: NF-κB forward, ACCTTTGCTGGAAACACACC and
reverse, ATGGCCTCGGAAGTTTCTTT; GAPDH forward,
GTTACCAGGGCT and reverse, GGGTTTCCCGTT.
2.18. Statistical analysis
Data were expressed as mean ± S.E.M. Results were analyzed
statistically by one-way analysis of variance (ANOVA) followed by
Tukey's post-hoc test. Diﬀerences between groups were considered to
be signiﬁcant when P < 0.05.
3. Results
3.1. Gross evaluation of gastric tissue
Macroscopic appearances of the gastric mucosa and gastric ulcer
index are shown in Fig. 1B and C, respectively. Mice in the normal
control and MSM only-treated groups showed intact stomach without
any lesions. Mice treated with ethanol/HCl showed extensive hemor-
rhagic necrosis in the glandular part of the gastric mucosa.
Pretreatment of mice with MSM (200 and 400 mg/kg) signiﬁcantly
reduced ethanol-induced gastric mucosal lesions and ulcer index as
compared to ethanol/HCl group. Our preliminary experiment showed
that the threshold dose of MSM for a signiﬁcant inhibitory eﬀect
against ethanol/HCl-induced gastric mucosal lesions was 200 mg/kg.
With low doses of MSM, the gastric mucosal damage and ulcer index
were not decreased signiﬁcantly compared with the ethanol/HCl group.
3.2. Histopathological examination of gastric tissue
Histopathological appearances of the gastric mucosa and total
pathological scores are shown in Fig. 2A and B, respectively. No
histological changes were observed in gastric specimens taken from
mice in the normal and MSM only-treated groups. Oral administration
of acidiﬁed ethanol induced severe gastric mucosal damage, character-
ized by disruption of glandular structure, loss of epithelial cells,
inﬁltration of inﬂammatory cells, submucosal edema, and hemorrhage.
Pretreatment of mice with MSM (200 and 400 mg/kg) signiﬁcantly
reduced these histopathological changes caused by ethanol/HCl and
preserved mucosal epithelial integrity and glandular structure. As
shown in Fig. 2B, Animals pretreated with MSM (200 and 400 mg/
kg) showed less histopathological scores when compared with the
ethanol/HCl group.
3.3. Eﬀects of MSM on the levels of GSH, CAT and PGE2
As shown in Fig. 3, oxidative stress induced by ethanol/HCl leads to
the depletion of GSH and CAT and inhibition of PGE2 production in the
gastric tissue when compared with those in the normal control group.
Pretreatment with MSM (200 and 400 mg/kg) signiﬁcantly restored
the levels of GSH, CAT activity and PGE2 production in the gastric
tissue as compared with those in the ethanol/HCl group. These eﬀects
show the antioxidant and gastroprotective activity of MSM in this
experimental model.
3.4. Eﬀects of MSM on the levels of MDA and protein carbonyl
Administration of ethanol/HCl signiﬁcantly increased the levels of
MDA as a marker of lipid peroxidation and protein carbonyl as a
marker of protein oxidation in the gastric tissue in comparison to the
normal group (Table 1). However, pretreatment with MSM at dose of
200 and 400 mg/kg signiﬁcantly prevented ethanol/HCl induced
increase of MDA and protein carbonyl levels (P < 0.01).
3.5. Eﬀects of MSM on the levels of NO and MPO
Oral administration of ethanol/HCl signiﬁcantly increased NO
production and MPO activity in the gastric tissue as compared to the
to the normal control group (Fig. 4A and B). Pretreatment with MSM at
dose of 200 and 400 mg/kg signiﬁcantly reduced the formation of NO
and the level of MPO in the gastric tissue compared with the ethanol/
HCl group.
3.6. Eﬀects of MSM on the levels of pro-inﬂammatory cytokines
We examined the eﬀects of MSM on the production of proinﬂam-
matory cytokines TNF-α, IL-1β, IL-6 and chemokine MCP-1 in the
gastric tissue. As shown in Fig. 5, Ethanol/HCl administration pro-
duced a signiﬁcant increase in the levels of TNF-α, IL-1β, IL-6 and
MCP-1 as compared to the normal control group (P < 0.001).
However, MSM pretreatment (200 and 400 mg/kg) signiﬁcantly in-
hibited the upregulation of these inﬂammatory mediators. These
results demonstrate remarkable anti-inﬂammatory properties of MSM.
3.7. Eﬀects of MSM on the levels of MMP-9
Oral administration of ethanol/HCl signiﬁcantly increased the
levels of MMP-9 as a marker of inﬂammation in the gastric epithelial
cells (Fig. 6). Administration of MSM at dose of 200 and 400 mg/kg
signiﬁcantly inhibited the ethanol/HCl-induced increase in MMP-9
production (P < 0.05). This result shows that gastroprotective eﬀect of
MSM in mice is related to a reduction in MMP-9 production.
3.8. Eﬀects of MSM on the mRNA expression level of NF-kB
Examination of NF-κB mRNA expression by real-time PCR revealed
that the mRNA expression level of NF-κB in the gastric tissues of mice
treated with ethanol/HCl signiﬁcantly increased when compared with
normal control mice (P < 0.01) (Fig. 7). Pretreatment with MSM at
both doses (200 and 400 mg/kg) signiﬁcantly decreased the ethanol/
HCl-induced increase in NF-κB mRNA expression (P < 0.05).
4. Discussion
Peptic ulcer disease is one of the most prevalent gastrointestinal
disorders. Many studies have been carried out to ﬁnd out eﬀective
alternative drugs from natural resources for treatment of peptic ulcer
disease. In the present study, we demonstrated that MSM treatment
signiﬁcantly reduced gastric mucosal damage induced by ethanol/HCl.
To evaluate the possible mechanisms responsible for the gastroprotec-
tive eﬀect of MSM, we determined the oxidative and inﬂammatory
markers in gastric tissue.
Previous studies showed that ROS play an important role in the
initiation and progression of gastric mucosal damage. Various exogen-
ous agents such as ethanol can lead to excessive production of ROS in
gastric tissue. Oxygen derived molecules are able to induce lipid
peroxidation chain reactions. Lipid peroxidation process in gastric
epithelial cells disturbs the integrity and permeability of cell mem-
branes, which leads to cell death and promotes the formation of gastric
mucosal ulcers. Oxygen-derived free radicals can cause modiﬁcation of
the peptide chain, protein cross-linking and oxidation of amino acids in
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Fig. 2. (A) Histopathological appearance of gastric tissues in (a) normal, (b) MSM only (c) ethanol/HCl, (d) MSM (200 mg/kg) + ethanol/HCl and (e) MSM (400 mg/kg) + ethanol/HCl
groups. Mice treated with ethanol/HCl orally showed loss of epithelial cells, edema, neutrophil inﬁltration and hemorrhage. Pretreatment with MSM (200 and 400 mg/kg) decreased the
histological alterations induced by ethanol/HCl. The gastric tissue sections were analyzed by H&E staining (magniﬁcation is ×400). (B) Total pathological scores in the gastric mucosa.
The results are presented as the mean of the total score ± S.E.M. (n = 8). #P < 0.001 compared with normal group; *P < 0.05 compared with ethanol/HCl group.
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proteins and lead to the formation of protein carbonyl derivatives
(Pérez et al., 2017). An increase in lipid peroxidation and carbonyl
proteins was demonstrated in the experimental model of gastric
mucosal ulcers (Liu et al., 2016). In agreement with other studies,
our results showed that ethanol administration signiﬁcantly increased
the production of MDA and carbonyl proteins in the gastric tissue.
However, pretreatment with MSM signiﬁcantly prevented lipid perox-
idation and protein carbonylation process induced by ethanol. MSM
has been shown to decrease the plasma levels of MDA and protein
carbonyl in human (Nakhostin-Roohi et al., 2011). These ﬁndings
conﬁrm the antioxidant properties of MSM and therefore, its antiox-
idant eﬀects may represent an important mechanism by which MSM
prevents gastric mucosal damage induced by ethanol.
GSH as thiol-containing tripeptide is one of the crucial cellular
antioxidants, which is considered as an important intracellular defense
against oxidative damage induced by ROS. The gastric mucosa
possesses high levels of GSH which provides additional protection
against gastric acid and the oxidative compounds present in the diet
(Pérez et al., 2017). GSH is a potential scavenger of O2
•־, H2O2 and HO
•
and reduction of GSH renders the gastric epithelial cells more
susceptible to damage induced by oxidative compounds. Catalase is
an antioxidant enzyme that exerts a remarkable protective role in the
gastric epithelium against mucosal injury and inﬂammation. It has
been shown that ethanol-induced gastric damage is associated with a
signiﬁcant decrease of GSH and catalase levels in the gastric tissue
(Antonisamy et al., 2015; Amirshahrokhi and Khalili, 2016a). In the
present study, our results showed that administration of ethanol/HCl
signiﬁcantly decreased the levels of GSH and catalase activity in the
Fig. 3. Eﬀect of MSM on ethanol/HCl-induced changes in the levels of (A) GSH, (B) CAT
and (C) PGE2. Pretreatment with MSM (200 and 400 mg/kg) signiﬁcantly restored the
levels of GSH, CAT and PGE2 in the gastric tissue compared with the ethanol/HCl group.
Data are means ± S.E.M. (n = 8). #P < 0.001 compared with normal group; *P < 0.05,
**P < 0.01 compared with ethanol/HCl group.
Table 1
Effects of MSM on the gastric levels of MDA and protein carbonyl.
Groups MDA Protein carbonyl
(µM/mg protein) (nM/mg protein)
Normal 0.097 ± 0.003 3.34 ± 0.25
MSM 0.06 ± 0.009 2.73 ± 0.61
Ethanol/HCl 0.24 ± 0.019a 9.13 ± 0.72a
MSM (200) + ethanol/HCl 0.158 ± 0.02b 6.15 ± 0.64b
MSM (400) + ethanol/HCl 0.15 ± 0.01b 4.62 ± 0.6b
Data are means ± S.E.M. (n = 8).
a P < 0.001 compared with normal group.
b P < 0.01 compared with ethanol/HCl group.
Fig. 4. Eﬀects of MSM on the NO production (A) and MPO activity (B) in the gastric
tissue. Pretreatment with MSM (200 and 400 mg/kg) remarkably reduced the production
of NO and MPO activity in the gastric tissue compared with the ethanol/HCl group. Data
are means ± S.E.M. (n = 8). #P < 0.001 compared with normal group; *P < 0.05, **P <
0.001 compared with ethanol/HCl group.
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gastric tissue. We suggest that, the reduction of GSH and catalase levels
may result from their consumption because of neutralization of
ethanol-induced ROS and toxic products in the gastric tissue. MSM
pretreatment inhibited the depletion of GSH and restored catalase
activity in the gastric tissue of mice exposed to ethanol/HCl. It has been
reported that chronic MSM administration increases liver glutathione
content and shows hepatoprotective eﬀect against chemically-induced
oxidant stress (DiSilvestro et al., 2008). In our study, we propose that
MSM may increase the synthesis of GSH and then it is able to improve
survival of cells by preventing GSH depletion.
PGE2 is an endogenous gastroprotective mediator that reduces acid
secretion, stimulates mucus and bicarbonate secretion and accelerates
ulcer healing. PGE2 can also increase gastric mucosal blood ﬂow and
the resistance of epithelial cells to damage induced by exposure to
various noxious substances such as ethanol and NSAIDs (Wallace,
2008; El-Maraghy et al., 2015). In our study, ethanol/HCl administra-
tion resulted in a signiﬁcant decrease in the gastric levels of PGE2
however MSM pretreatment was able to increase the levels of PGE2.
NO, as an important biological mediator, plays a dual role in gastric
mucosa; at physiological concentrations, NO protects against gastric
mucosal injury; while at excessive production, it triggers tissue damage
(Elliott and Wallace, 1998; Das and Vasudevan, 2007). It has been
shown that oral administration of ethanol increases inducible nitric
Fig. 5. Eﬀect of MSM on (A) TNF-α, (B) IL-1β, (C) IL-6 and (D) MCP-1 production in gastric tissue of mice. Oral administration of ethanol/HCl increased the levels of TNF-α, IL-1β, IL-
6 and MCP-1 in gastric tissue, whereas pretreatment with MSM (200 and 400 mg/kg) prevented the ethanol/HCl-induced increase in TNF-α, IL-1β, IL-6 and MCP-1. Data are means ±
S.E.M. (n = 8). #P < 0.001 compared with normal group; *P < 0.05, **P < 0.01, ***P < 0.001 compared with ethanol/HCl group.
Fig. 6. Eﬀect of MSM on the plasma levels of MMP-9. Pretreatment with MSM inhibited
the ethanol/HCl-induced increase in MMP-9 levels. Data are means ± S.E.M. (n = 8). #P
< 0.001 compared with normal group; *P < 0.05, compared with ethanol/HCl group.
Fig. 7. Eﬀect of MSM pretreatment on ethanol/HCl-induced increase in NF-κB2 mRNA
expression in gastric tissue. The mRNA levels were normalized by the expression of
GAPDH. Data are means ± S.E.M. of three experiments. #P < 0.01 compared with
normal group; *P < 0.05 compared with ethanol/HCl group.
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oxide synthase (iNOS) expression in the gastric tissue, leading to NO
overproduction and subsequently gastric mucosal cell damage (Yu
et al., 2014). Under pathophysiological conditions, NO causes cell
injury through direct cytotoxic eﬀects and free radicals generation
(Amirshahrokhi and Khalili, 2015b). In the present study, our ﬁndings
showed that oral administration of ethanol results in an increase in the
levels of NO in the gastric tissue while pretreatment with MSM
signiﬁcantly reduced ethanol-induced NO production. This ﬁnding
suggests that inhibition of NO-mediated cytotoxicity is probably
involved in the gastroprotective action of MSM. In agreement with
this ﬁnding, it has been reported that MSM is able to reduce NO
production in various cells (Kim et al., 2015; Karabay et al., 2014).
The inﬁltration of neutrophils into the gastric mucosa plays an
important role in the progression of gastric mucosal inﬂammation and
damage. Activated macrophages and neutrophils release several proin-
ﬂammatory mediators and ROS during gastric inﬂammation. MPO is a
peroxidase enzyme found in the neutrophils and has been used
extensively as a biochemical marker of neutrophil inﬁltration into the
damaged tissue (Amirshahrokhi and Khalili, 2015a; Watanabe et al.,
2004). In this study, we observed that ethanol/HCl administration
signiﬁcantly increased the MPO activity in the stomach, indicating
gastric mucosal inﬂammation. Pretreatment with MSM caused a
signiﬁcant reduction of the inﬂammatory cell inﬁltration and MPO
activity in the gastric tissue. This result reveals that MSM may possess
gastroprotective eﬀects through inhibition of gastric mucosal inﬂam-
mation. Furthermore, the ability of MSM to inhibit MPO activity has
been shown in other experimental models (Bohlooli et al., 2013;
Amirshahrokhi et al., 2011; Marañón et al., 2008). These ﬁndings
were also supported by histological analysis of the gastric mucosa. Our
histological examination showed that ethanol/HCl administration
induced gastric submucosal edema, neutrophil inﬁltration, loss of
epithelial cells and severe hemorrhage, while pretreatment with MSM
reduced these histological alterations and pathologic score in the
gastric tissue of animals receiving ethanol/HCl.
Many studies have shown that proinﬂammatory cytokines TNF-α,
IL-1β, IL-6 and chemokine MCP-1 are involved in the pathogenesis of
gastric mucosal injury. TNF-α plays an important role in the pathogen-
esis of various gastrointestinal diseases including colitis, gastric cancer
and gastritis as well as hepatitis (Amirshahrokhi et al., 2010; Chang
et al., 2015; Amirshahrokhi and Khalili, 2016a). TNF-α can induce a
cascade of events leading to neutrophil activation, up regulation of
adhesion molecules and the production and release of other cytokines
and chemokines. TNF-α stimulates immune cells to generate toxic
metabolites and reduces gastric microcirculation around ulcerated
mucosa and delays its healing (Verma and Kumar, 2016; Arab et al.,
2015). IL-1β and IL-6 are potent proinﬂammatory cytokines synthe-
sized mainly by activated monocytes and macrophages. It has been
reported that the levels of these cytokines in serum and gastric tissue
correlate with the severity of gastric mucosal inﬂammation (Li et al.,
2014). MCP-1 is a member of the CC chemokine family and plays an
important role in the regulation of leukocyte recruitment at sites of
inﬂammation in several diseases. There are many studies demonstrat-
ing increased levels of chemokines MCP-1 and IL-8 in gastric mucosal
inﬂammation and damage induced by NSAIDs, ethanol and H. pylori.
The main source of MCP-1 is inﬂammatory cells and increased levels of
MCP-1 could be due to an increase in the number of macrophages and
neutrophils in injured gastric mucosa (Watanabe et al., 2004;
Amirshahrokhi and Khalili, 2016a). In agreement with previous
studies, we also showed that the administration of ethanol/HCl caused
an increase in the levels of TNF-α, IL-1β, IL-6 and MCP-1 in the gastric
tissue and pretreatment with MSM signiﬁcantly decreased the levels of
these proinﬂammatory mediators. The ability of MSM to inhibit
proinﬂammatory cytokines has been shown in various experimental
models (Ahn et al., 2015; Karabay et al., 2014; Sousa-Lima et al.,
2016).
NF-κB is an important transcription factor that mediates pivotal
inﬂammatory events in gastric damage induced by various agents
including ethanol. NF-κB is a redox-sensitive transcription factor that
regulates cellular responses to ROS and inﬂammatory mediators.
Activation of NF-κB induces the expression of TNF-α, IL-1β, IL-6,
MCP-1 and several other adhesion molecules. Moreover, NF-κB
induces the expression of iNOS, which catalyzes the production of
NO in response to a variety of stress conditions (Arab et al., 2015;
Amirshahrokhi and Khalili, 2016b; Pérez et al., 2017). It has also been
shown that NF-κB is a key mediator to induce inﬂammatory protein
MMP-9 which contributes to gastric inﬂammation and injury. MMP-9
is one of the most important members of the metalloproteinase family
and involves in the dysregulation of extracellular matrix remodeling
during gastric ulcer formation. MMP-9 is produced by inﬂammatory
and epithelial cells under the inﬂuence of inﬂammatory mediators and
ROS (Li et al., 2014; Swarnakar et al., 2007). In the present study, we
demonstrated that ethanol administration induced NF-κB expression
and pretreatment with MSM signiﬁcantly reduced ethanol-induced NF-
κB activation in the gastric tissue. Indeed, the gastroprotective eﬀect of
MSM in mice is related to a reduction in NF-κB signaling pathway. It
has been reported that the inhibitory eﬀect of MSM on NF-κB
activation results in the downregulation of mRNA for IL-1, IL-6 and
TNF-α (Butawan et al., 2017). Moreover the plasma levels of MMP-9,
as a marker of gastric inﬂammation, were inhibited by MSM pretreat-
ment.
5. Conclusion
The ﬁndings of the present study demonstrate that pretreatment
with MSM inhibits the oxidative and inﬂammatory mediators in the
gastric tissue and can be used as a potential gastroprotective agent.
However clinical use of MSM in gastric mucosal damage in humans
should be further investigated.
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